Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Here we describe the expression and function of a HIF-1-regulated protein pyruvate dehydrogenase kinase-1 (PDK-1) in head and neck squamous cancer (HNSCC). Using RNAi to downregulate hypoxia-inducible PDK-1, we found that lactate and pyruvate excretion after 16-48 h of hypoxia was suppressed to normoxic levels. This indicates that PDK-1 plays an important role in maintaining glycolysis. Knockdown had no effect on proliferation or survival under hypoxia. The immunohistochemical expression of PDK-1 was assessed in 140 cases of HNSCC. PDK-1 expression was not expressed in normal tissues but was upregulated in HNSCC and found to be predominantly cytoplasmic with occasional strong focal nuclear expression. It was strongly related to poor outcome (P=0.005 split by median). These results indicate that HIF regulation of PDK-1 has a key role in maintaining lactate production in human cancer and that the investigation of PDK-1 inhibitors should be investigated for antitumour effects.

Original publication

DOI

10.1038/sj.bjc.6604356

Type

Journal article

Journal

Br J Cancer

Publication Date

17/06/2008

Volume

98

Pages

1975 - 1984

Keywords

Base Sequence, Carcinoma, Squamous Cell, Cell Line, Tumor, DNA Primers, Gene Silencing, Head and Neck Neoplasms, Humans, Hypoxia, Lactic Acid, Polymerase Chain Reaction, Prognosis, Protein-Serine-Threonine Kinases, RNA Interference